The global neurovascular devices market size accounted for USD 3.02 billion in 2024, grew to USD 3.27 billion in 2025 and is predicted to surpass around USD 6.64 billion by 2034, representing a healthy CAGR of 8.20% between 2025 and 2034. The North America neurovascular devices market size was calculated at USD 940 million in 2024 and is expected to grow at a fastest CAGR of 8.32% during the forecast year.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Neurovascular Devices Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Neurovascular Devices Market, by Device Type
8.1.1. Cerebral Angioplasty & Stenting Systems
8.1.1.1. Market Revenue and Forecast
8.1.2. Support Devices
8.1.2.1. Market Revenue and Forecast
8.1.3. Cerebral Embolization & Aneurysm Coiling Devices
8.1.3.1. Market Revenue and Forecast
8.1.4. Neurothrombectomy Devices
8.1.4.1. Market Revenue and Forecast
9.1. Neurovascular Devices Market, by Application
9.1.1. Cerebral Aneurysm
9.1.1.1. Market Revenue and Forecast
9.1.2. Cerebral Artery Stenosis
9.1.2.1. Market Revenue and Forecast
9.1.3. Stroke
9.1.3.1. Market Revenue and Forecast
9.1.4. Others
9.1.4.1. Market Revenue and Forecast
10.1. North America
10.1.1. Market Revenue and Forecast, by Device
10.1.2. Market Revenue and Forecast, by Application
10.1.3. U.S.
10.1.3.1. Market Revenue and Forecast, by Device
10.1.3.2. Market Revenue and Forecast, by Application
10.1.4. Rest of North America
10.1.4.1. Market Revenue and Forecast, by Device
10.1.4.2. Market Revenue and Forecast, by Application
10.2. Europe
10.2.1. Market Revenue and Forecast, by Device
10.2.2. Market Revenue and Forecast, by Application
10.2.3. UK
10.2.3.1. Market Revenue and Forecast, by Device
10.2.3.2. Market Revenue and Forecast, by Application
10.2.4. Germany
10.2.4.1. Market Revenue and Forecast, by Device
10.2.4.2. Market Revenue and Forecast, by Application
10.2.5. France
10.2.5.1. Market Revenue and Forecast, by Device
10.2.5.2. Market Revenue and Forecast, by Application
10.2.6. Rest of Europe
10.2.6.1. Market Revenue and Forecast, by Device
10.2.6.2. Market Revenue and Forecast, by Application
10.3. APAC
10.3.1. Market Revenue and Forecast, by Device
10.3.2. Market Revenue and Forecast, by Application
10.3.3. India
10.3.3.1. Market Revenue and Forecast, by Device
10.3.3.2. Market Revenue and Forecast, by Application
10.3.4. China
10.3.4.1. Market Revenue and Forecast, by Device
10.3.4.2. Market Revenue and Forecast, by Application
10.3.5. Japan
10.3.5.1. Market Revenue and Forecast, by Device
10.3.5.2. Market Revenue and Forecast, by Application
10.3.6. Rest of APAC
10.3.6.1. Market Revenue and Forecast, by Device
10.3.6.2. Market Revenue and Forecast, by Application
10.4. MEA
10.4.1. Market Revenue and Forecast, by Device
10.4.2. Market Revenue and Forecast, by Application
10.4.3. GCC
10.4.3.1. Market Revenue and Forecast, by Device
10.4.3.2. Market Revenue and Forecast, by Application
10.4.4. North Africa
10.4.4.1. Market Revenue and Forecast, by Device
10.4.4.2. Market Revenue and Forecast, by Application
10.4.5. South Africa
10.4.5.1. Market Revenue and Forecast, by Device
10.4.5.2. Market Revenue and Forecast, by Application
10.4.6. Rest of MEA
10.4.6.1. Market Revenue and Forecast, by Device
10.4.6.2. Market Revenue and Forecast, by Application
10.5. Latin America
10.5.1. Market Revenue and Forecast, by Device
10.5.2. Market Revenue and Forecast, by Application
10.5.3. Brazil
10.5.3.1. Market Revenue and Forecast, by Device
10.5.3.2. Market Revenue and Forecast, by Application
10.5.4. Rest of LATAM
10.5.4.1. Market Revenue and Forecast, by Device
10.5.4.2. Market Revenue and Forecast, by Application
11.1. Medtronic
11.1.1. Company Overview
11.1.2. Product Offerings
11.1.3. Financial Performance
11.1.4. Recent Initiatives
11.2. MicroPort Scientific Corporation
11.2.1. Company Overview
11.2.2. Product Offerings
11.2.3. Financial Performance
11.2.4. Recent Initiatives
11.3. Penumbra, Inc.
11.3.1. Company Overview
11.3.2. Product Offerings
11.3.3. Financial Performance
11.3.4. Recent Initiatives
11.4. Stryker Corporation
11.4.1. Company Overview
11.4.2. Product Offerings
11.4.3. Financial Performance
11.4.4. Recent Initiatives
11.5. Johnson & Johnson Services, Inc.
11.5.1. Company Overview
11.5.2. Product Offerings
11.5.3. Financial Performance
11.5.4. Recent Initiatives
11.6. MicroVention, Inc.
11.6.1. Company Overview
11.6.2. Product Offerings
11.6.3. Financial Performance
11.6.4. Recent Initiatives
11.7. Codman Neuro
11.7.1. Company Overview
11.7.2. Product Offerings
11.7.3. Financial Performance
11.7.4. Recent Initiatives
12.1. Primary Research
12.2. Secondary Research
12.3. Assumptions
13.1. About Us
13.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample